Financials
- Market Capitalization 12.52 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
33.02
市销率
3.64
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 710 | BBIO BridgeBio Pharma, Inc. - Common Stock | 76.60 USD | -2.64% | -5.42% | -9.48% | +34.39% | 14.97 B USD | ||
| 761 | EXEL Exelixis, Inc. - Common Stock | 54.45 USD | -1.47% | +1.04% | -3.54% | +39.47% | 13.49 B USD | ||
| 809 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 533.76 USD | -1.83% | +3.24% | -1.45% | +26.00% | 12.33 B USD | ||
| 810 | CORT Corcept Therapeutics Incorporated - Common Stock | 113.88 USD | -2.61% | -5.54% | +19.87% | +55.21% | 12.31 B USD |